NPPB and cardiac amyloidosis: Likewise, staging systems, which include biomarkers like NTproBNP (N-terminal prohormone of brain natriuretic peptide) and high sensitivity cTnT (cardiac Troponin T), or decreased estimated glomerular filtration rate (eGFR) were proposed for ATTR cardiac amyloidosis [39,40].